share_log

Cognition Therapeutics | 8-K: Cognition Therapeutics Reports Financial Results for the Second Quarter 2024 and Provides Business and Clinical Update

SEC ·  Aug 8 07:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more